HK Stock Market Move | SHINEWAY PHARM (02877) soared 12% in the afternoon, with first-half performance down more than 20%. It plans to distribute a second interim dividend of 80 cents.

SHINEWAY PHARM (02877) surged 12% in the afternoon, and as of the time of writing, it was up 8%, trading at HKD 8.57, with a transaction volume of HKD 36.2243 million. On the news front, SHINEWAY PHARM released its interim results, showing a revenue of RMB 1.181 billion for the first half of the year, a year-on-year decrease of 28.5%; profit for the period was RMB 469 million, down 23.7% year-on-year; basic earnings per share were 62 cents; and the company plans to distribute a second interim dividend of 80 cents. The announcement stated that the overall gross profit margin of the group fell from 72.2% in the same period last year to 69.9%, affected by declining sales volume and price drops due to centralized procurement, along with persistently high production costs. The group continues to focus its development strategy on expanding oral formulations. In the first six months of 2026, oral products accounted for 72.9% of total sales, while injectable products made up 27.1% of total sales.